aTyr Pharma holds special stockholder meeting
ATYR•aTyr Pharma shareholders approved charter amendments authorizing a reverse stock split at the October 16, 2026, special meeting; the board may choose a ratio from 1-for-10 to 1-for-50.
1. Shareholders approve amendments
Shareholders approved charter amendments authorizing a reverse stock split at the October 16, 2026, special meeting. The board retains discretion over whether to implement the split and may select a ratio between 1-for-10 and 1-for-50, inclusive.
